Biotech Values

[daved]

Call my believing the 10K quote, "LEO will pay us at cost for all product used in clinical studies" a lack of homework. Fine.

The first reference to inventory costs in excess of LEO transfer price appeared in the August 10Q, 10 months after the agreement. I considered that a "new disclosure".

Calling me names does not change the fact that my main focuses were concern over the product costs for the LEO (not LFB) deal and the fact that they appeared only in the 10Qs under R & D expense.

Dave